# Kazuhiro Sakakibara

> Kazuhiro Sakakibara is a Series A investor at ANRI backing Health Care and Medical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ANRI](https://shizune.co/investors/profile/anri)
- Total investments: 5
- Last investment: Jun 2026
- Lead investor: 0%
- Last updated: Aug 2026

Kazuhiro Sakakibara is a Series A investor at ANRI focused on Health Care and Medical. Kazuhiro Sakakibara is the Senior Associate at ANRI.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Medical | 2 | 40% |
| Biotechnology | 2 | 40% |
| Therapeutics | 1 | 20% |
| Pharmaceutical | 1 | 20% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 1 | 20% |
| Pre-Seed | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Arrowsmith | Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of bacterial infectious diseases. Through transformative science, Arrowsmith strive to create a world free from the pain and fear caused by antimicrobial resistance. | $6.5M | Series A | Jun 22, 2026 |  |
| xCARE | xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries. | $3.7M | Series A | Jun 08, 2026 |  |
| FerroptoCure | FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases. | $3.1M | Series A | Sep 19, 2025 |  |
| xCARE | xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries. | $862.5K | Seed | Feb 13, 2024 |  |
| Ruten | Ruten is a brain-machine interface company that specializes in reconstructive treatments for infeasible and ineffective conditions. | $500K | Pre-Seed | Nov 01, 2023 |  |

5 of 5 investments shown.

## Co-investors
- [Chugin Capital Partner](https://shizune.co/investors/profile/chugin-capital-partner) — VC Fund, 2 deals together
- [TUSIC](https://shizune.co/investors/profile/tusic) — VC Fund, 2 deals together
- [CyberAgent Capital](https://shizune.co/investors/profile/cyberagent) — VC Fund, 1 deal together
- [DBJ Capital](https://shizune.co/investors/profile/dbj-capital) — VC Fund, 1 deal together
- [Diamond Medino Capital](https://shizune.co/investors/profile/diamond-medino-capital) — VC Fund, 1 deal together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 1 deal together

## About ANRI

VC Fund · Tokyo, Japan

ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.

5 contacts available at ANRI.

| Name | Title | Profile |
| --- | --- | --- |
| Anri Samata | Partner; Founder & General Partner | https://shizune.co/investors/profile/yuri-samata |
| Anri Samata | Founder & General Partner | https://shizune.co/investors/profile/anri-samata-6e86 |
| Junichiro Kono | General Partner | https://shizune.co/investors/profile/junichiro-kono |
| Kazuhiro Sakakibara | Senior Associate | https://shizune.co/investors/profile/kazuhiro-sakakibara |
| Masahiro Sameshima | General Partner | https://shizune.co/investors/profile/masahiro-sameshima |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Kazuhiro Sakakibara invest in?

Kazuhiro Sakakibara invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kazuhiro Sakakibara last invest?

The most recent investment recorded for Kazuhiro Sakakibara closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co